Urethral Cancer: Symptoms, Diagnosis & Treatment

What Is Urethral Cancer?

Urethral cancer is a rare form of cancer that develops in the urethra, the tube that carries urine from the bladder to the outside of the body. Also known as urethral carcinoma, this condition occurs when abnormal cells in the urethral lining begin to grow uncontrollably.

Although uncommon compared to bladder, prostate, or kidney cancer, urethral cancer requires timely medical attention. Early diagnosis can improve treatment outcomes and expand the range of available treatment options.

Urethral cancer can affect both men and women, although it is diagnosed more frequently in men. The disease may develop in different parts of the urethra and can vary in behavior depending on the type of cancer cells involved.

Book an Appointment

Key Facts About Urethral Cancer

Urethral cancer is one of the rarest urological cancers, accounting for approximately 1-2% of urinary tract malignancies.
Men are affected more often than women overall, though women are more commonly affected by certain subtypes, such as adenocarcinoma.
Previous bladder cancer significantly increases the risk of developing urethral carcinoma and warrants ongoing surveillance.
Symptoms often overlap with benign urological conditions, including urethral stricture, urethral diverticulum, urethral caruncle, or complications from long-term catheterization.
Early-stage disease is generally more treatable than advanced or metastatic disease.
Treatment may involve surgery, radiation therapy, chemotherapy, immunotherapy, or a multimodal combination of approaches.

Types of Urethral Cancer

Doctors classify types of urethral cancer based on the type of cells where the tumor originates.

Transitional (Urothelial) Cell Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma

Stages of Urethral Cancer

Before deciding on treatment, the oncology team evaluates the location of the tumor and applies the TNM (Tumor, Node, Metastasis) classification system to determine the extent of disease. The resulting classification is used to identify urethral cancer stages and guide treatment planning.

By Location

Anterior urethral cancer
Posterior urethral cancer

By Stage of Spread

Stage 0 (carcinoma in situ)
Stage 1
Stage 2
Stage 3
Stage 4

Symptoms of Urethral Cancer

The signs and symptoms of urethral cancer can vary from person to person and may overlap with benign urological conditions such as urethral stricture, urethral diverticulum, urethral caruncle, or complications related to long-term catheterization. This overlap sometimes leads to delayed diagnosis or initial treatment for the wrong condition.

Common symptoms of urethral cancer include:

Hematuria (blood in the urine)
Pain or burning sensation during urination (dysuria)
Weak or interrupted urine stream due to urethral obstruction
Urethral discharge without an obvious infectious cause
A palpable lump or thickening along the urethra or in the perineum
Swollen lymph nodes in the groin (inguinal lymphadenopathy)

Because these symptoms can occur in many urological conditions, medical evaluation is essential for anyone experiencing persistent or recurrent complaints lasting more than one to two weeks.

Causes and Risk Factors

The exact cause of urethral cancer is not fully understood. Like most cancers, it likely results from a combination of genetic changes in urethral cells and external factors that promote abnormal cell growth. Several factors have been consistently identified in individuals who receive this diagnosis.

Sexually Transmitted Infections (STIs)
Smoking
Chronic Irritation and Inflammation

Other Risk Factors

Age: The risk of urethral cancer increases with advancing age, likely due to cumulative exposure to contributing factors over time.
History of bladder cancer: Individuals with a previous diagnosis of bladder cancer have a higher likelihood of developing urethral carcinoma, sometimes years after the initial diagnosis.
Sex: Men are diagnosed with urethral cancer more frequently overall, although women are more commonly affected by certain subtypes, such as adenocarcinoma.
Race: Some studies suggest a slightly higher incidence in certain populations, though epidemiological data on racial differences remain limited.
Long-term catheter use: Prolonged indwelling catheterization can cause chronic mucosal irritation, increasing the risk of urethral cancer.

When to See an Oncologist

Persistent urinary symptoms should never be ignored or self-managed without a proper diagnosis. Consult a specialist promptly if you experience any of the following:

Blood in the urine (hematuria): Lasting more than a few days.
Difficulty or pain during urination: That does not resolve.
A palpable mass or thickening: Near the urethra or in the perineum.
Persistent pelvic discomfort or unexplained urethral discharge.
Recurrent urinary symptoms: Without a clear infectious cause.
Unexplained swelling of lymph nodes:In the groin.

Individuals with known risk factors, including a history of bladder cancer, recurrent STIs, or long-term catheter use, should discuss proactive screening with their treating physician. Waiting for symptoms to become severe is one of the key factors that leads to later-stage diagnoses and more complex treatment courses.

How Is Urethral Cancer Diagnosed?

Diagnosis of urethral cancer requires a structured sequence of evaluations. No single test confirms the diagnosis; rather, the workup proceeds from clinical assessment to specialized investigations as needed.

Diagnostic methods may include:

Clinical history and physical examination
Laboratory tests
Imaging studies
Endoscopy
Biopsy

Treatment Options for Urethral Cancer

Urethral cancer is treatable. The appropriate treatment of urethral cancer depends on the cancer type, stage of disease, tumor location, and the patient’s overall health. Most cases are managed by a multidisciplinary team bringing together urology, surgical oncology, medical oncology, and radiation oncology.

Surgery

Surgery is the cornerstone of urethral cancer treatment, aiming to achieve clear surgical margins by removing the tumor along with a rim of healthy surrounding tissue. Smaller anterior urethral tumors may be treated with limited resection, whereas larger or posterior urethral tumors often require more radical surgery.
The surgical approach is individualized to maximize oncological outcomes while preserving urinary and sexual function and maintaining quality of life whenever possible.

Chemotherapy

Chemotherapy may be used before or after surgery. Neoadjuvant chemotherapy helps reduce tumor bulk and improve resectability, while adjuvant chemotherapy targets residual micrometastatic disease following surgery.
In patients with unresectable or metastatic disease, chemotherapy may serve as the primary treatment. Drug selection, dosing, and scheduling are based on the histological subtype and the patient's tolerance.

Radiation Therapy

Radiation therapy uses high-energy beams to destroy cancer cells and may be delivered through external beam radiation therapy (EBRT) or brachytherapy, depending on tumor size and location.
It can be used as a primary treatment, combined with chemotherapy (chemoradiation), or given after surgery to manage margins or regional disease. In advanced cases, palliative radiation helps relieve pain and other complications.

Immunotherapy

Immunotherapy, particularly immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway, enhances the immune system's ability to recognize and attack cancer cells.
Although not currently part of the standard treatment protocol for urethral cancer due to limited disease-specific clinical data, immunotherapy remains an active area of investigation, and eligible patients may access these therapies through clinical trials after failure of surgery, chemotherapy, or radiation.

Can Urethral Cancer Be Prevented?

There is no guaranteed method to prevent urethral cancer, but several evidence-backed measures can meaningfully reduce risk:

Avoid tobacco use: Carcinogens excreted in urine directly damage the urethral mucosa.
Use condoms consistently: To reduce the risk of HPV and other sexually transmitted infections.
Consider HPV vaccination: Targeting HPV-16 and HPV-18 for eligible individuals.
Seek prompt treatment for chronic urological conditions:Such as urethral strictures, diverticula, or recurrent infections.
Follow strict hygiene protocols with long-term indwelling catheters and discuss monitoring with the treating team.
Attend regular follow-up appointments if you have a prior history of bladder cancer or other urological malignancies.

Expert Urethral Cancer Care at HCG

HCG Cancer Hospital offers multidisciplinary care for patients diagnosed with urethral cancer. Our team of urologists, surgical oncologists, medical oncologists, and radiation oncologists collaborates through centralized tumor boards to develop individualized treatment plans aligned to each patient’s cancer type, stage, and overall health profile.

Advanced diagnostic technologies, minimally invasive robotic surgery, and precision radiation platforms, including CyberKnife and TrueBeam, ensure patients receive comprehensive, evidence-based care at every stage of their journey. Book a consultation with HCG’s specialists today for a thorough evaluation and personalized treatment roadmap.

Frequently Asked Questions

Is urethral cancer curable?

Many patients diagnosed at an early stage achieve favorable outcomes, with prognosis depending primarily on the stage at diagnosis, cancer type, and individual patient factors.

Is urethral cancer common?

No, urethral cancer is a rare malignancy that accounts for approximately 1–2% of all urinary tract cancers and occurs much less frequently than bladder, prostate, or kidney cancer.

Who is at higher risk of urethral cancer?

Individuals with a history of bladder cancer, chronic urethral irritation, smoking, HPV infection (particularly HPV-16 and HPV-18), recurrent STIs such as chlamydia or gonorrhea, or long-term indwelling catheter use have an increased risk.

What are the symptoms of urethral cancer in women?

Women may experience hematuria, dysuria, urinary frequency, urethral discharge, or a palpable mass near the urethral opening, although these symptoms can resemble those of urinary tract infections and other benign conditions.

Where does urethral cancer spread first?

Urethral cancer most commonly spreads first to nearby tissues and regional lymph nodes, particularly the inguinal and pelvic nodes, before potentially reaching distant organs such as the lungs, liver, or bones.

What specialist treats urethral cancer?

Treatment is typically managed by a multidisciplinary team that may include a urologist, surgical oncologist, medical oncologist, and radiation oncologist.

How aggressive is urethral cancer?

The aggressiveness of urethral cancer varies according to its histological type and stage, with early-stage disease often responding well to treatment, while advanced cancers with lymph node involvement or distant metastasis may progress rapidly and require intensive multimodal therapy.

Disclaimer: This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare provider for any questions regarding a medical condition.

Urethral Cancer